CD79A and interstitial lung disease: On the contrary, GL-ILD-treated patients presented lower MZ B cells percentage (p=0.0181) and higher CD21low B cells percentage (p=0.0035), whereas low IgA levels (in GL-ILD-treated patients vs untreated) where close to reach statistical significance (p=0.0802).